Back to discover
Disease

Carcinoma, Ductal, Breast

Active therapeutic pipelineEmerging research
2
Publications
5
Clinical trials
1
Related conditions
12
Associated genes
2
Related proteins
2018
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Research2018-03-01Journal of the National Comprehensive Cancer Network : JNCCN

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Research2008-02-04Journal of clinical oncology : official journal of the American Society of Clinical Oncology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2037.
Major developments
Upcoming trial readoutImportant
Results expected Q4 20372026-08-13
Clinical Milestones1View

Clinical trials

5 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20082018
Most influential

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2008 · 2,150 cites

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN · 2018 · 276 cites
Recent publications

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN · 2018 · 276 cites

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2008 · 2,150 cites
Major themes1
  • Neoadjuvant Therapy1
Leading journals2
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
  • Journal of the National Comprehensive Cancer Network : JNCCN1
Leading researchers8
  • Anderson BO1
  • André F1
  • Balassanian R1
  • Blair SL1
  • Burstein HJ1
  • Cristofanilli M1
  • Cyr A1
  • Elias AD1
Affiliations (unnormalised)1
  • The University of Texas M.D. Anderson Cancer Center1

Associated genes

12 matches

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

2 matches

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.